Wireless versus routine physiologic monitoring after cesarean delivery to reduce maternal morbidity and mortality in a resource-limited setting: protocol of type 2 hybrid effectiveness-implementation study.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
12 Feb 2021
Historique:
received: 18 12 2020
accepted: 08 01 2021
entrez: 13 2 2021
pubmed: 14 2 2021
medline: 15 5 2021
Statut: epublish

Résumé

Women in sub-Saharan Africa have the highest rates of morbidity and mortality during childbirth globally. Despite increases in facility-based childbirth, gaps in quality of care at facilities have limited reductions in maternal deaths. Infrequent physiologic monitoring of women around childbirth is a major gap in care that leads to delays in life-saving interventions for women experiencing complications. We will conduct a type-2 hybrid effectiveness-implementation study over 12 months to evaluate using a wireless physiologic monitoring system to detect and alert clinicians of abnormal vital signs in women for 24 h after undergoing emergency cesarean delivery at a tertiary care facility in Uganda. We will provide physiologic data (heart rate, respiratory rate, temperature and blood pressure) to clinicians via a smartphone-based application with alert notifications if monitored women develop predefined abnormalities in monitored physiologic signs. We will alternate two-week intervention and control time periods where women and clinicians use the wireless monitoring system during intervention periods and current standard of care (i.e., manual vital sign measurement when clinically indicated) during control periods. Our primary outcome for effectiveness is a composite of severe maternal outcomes per World Health Organization criteria (e.g. death, cardiac arrest, jaundice, shock, prolonged unconsciousness, paralysis, hysterectomy). Secondary outcomes include maternal mortality rate, and case fatality rates for postpartum hemorrhage, hypertensive disorders, and sepsis. We will use the RE-AIM implementation framework to measure implementation metrics of the wireless physiologic system including Reach (proportion of eligible women monitored, length of time women monitored), Efficacy (proportion of women with monitoring according to Uganda Ministry of Health guidelines, number of appropriate alerts sent), Adoption (proportion of clinicians utilizing physiologic data per shift, clinical actions in response to alerts), Implementation (fidelity to monitoring protocol), Maintenance (sustainability of implementation over time). We will also perform in-depth qualitative interviews with up to 30 women and 30 clinicians participating in the study. This is the first hybrid-effectiveness study of wireless physiologic monitoring in an obstetric population. This study offers insights into use of wireless monitoring systems in low resource-settings, as well as normal and abnormal physiologic parameters among women delivering by cesarean. ClinicalTrials.gov , NCT04060667 . Registered on 08/01/2019.

Sections du résumé

BACKGROUND BACKGROUND
Women in sub-Saharan Africa have the highest rates of morbidity and mortality during childbirth globally. Despite increases in facility-based childbirth, gaps in quality of care at facilities have limited reductions in maternal deaths. Infrequent physiologic monitoring of women around childbirth is a major gap in care that leads to delays in life-saving interventions for women experiencing complications.
METHODS METHODS
We will conduct a type-2 hybrid effectiveness-implementation study over 12 months to evaluate using a wireless physiologic monitoring system to detect and alert clinicians of abnormal vital signs in women for 24 h after undergoing emergency cesarean delivery at a tertiary care facility in Uganda. We will provide physiologic data (heart rate, respiratory rate, temperature and blood pressure) to clinicians via a smartphone-based application with alert notifications if monitored women develop predefined abnormalities in monitored physiologic signs. We will alternate two-week intervention and control time periods where women and clinicians use the wireless monitoring system during intervention periods and current standard of care (i.e., manual vital sign measurement when clinically indicated) during control periods. Our primary outcome for effectiveness is a composite of severe maternal outcomes per World Health Organization criteria (e.g. death, cardiac arrest, jaundice, shock, prolonged unconsciousness, paralysis, hysterectomy). Secondary outcomes include maternal mortality rate, and case fatality rates for postpartum hemorrhage, hypertensive disorders, and sepsis. We will use the RE-AIM implementation framework to measure implementation metrics of the wireless physiologic system including Reach (proportion of eligible women monitored, length of time women monitored), Efficacy (proportion of women with monitoring according to Uganda Ministry of Health guidelines, number of appropriate alerts sent), Adoption (proportion of clinicians utilizing physiologic data per shift, clinical actions in response to alerts), Implementation (fidelity to monitoring protocol), Maintenance (sustainability of implementation over time). We will also perform in-depth qualitative interviews with up to 30 women and 30 clinicians participating in the study.
DISCUSSION CONCLUSIONS
This is the first hybrid-effectiveness study of wireless physiologic monitoring in an obstetric population. This study offers insights into use of wireless monitoring systems in low resource-settings, as well as normal and abnormal physiologic parameters among women delivering by cesarean.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov , NCT04060667 . Registered on 08/01/2019.

Identifiants

pubmed: 33579213
doi: 10.1186/s12884-021-03550-w
pii: 10.1186/s12884-021-03550-w
pmc: PMC7880025
doi:

Banques de données

ClinicalTrials.gov
['NCT04060667']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

124

Subventions

Organisme : NICHD NIH HHS
ID : K23 HD097300
Pays : United States
Organisme : NIMH NIH HHS
ID : K24 MH114732
Pays : United States
Organisme : Eunice Kennedy Shriver National Institute of Child Health and Human Development
ID : HD097300-01
Organisme : NIMH NIH HHS
ID : K24MH114732
Pays : United States

Références

Ann Behav Med. 2007 Oct;34(2):105-14
pubmed: 17927550
Lancet. 2006 Sep 30;368(9542):1189-200
pubmed: 17011946
Lancet. 2016 Oct 29;388(10056):2176-2192
pubmed: 27642019
Int J Gynaecol Obstet. 1996 Jul;54(1):1-10
pubmed: 8842811
Lancet Glob Health. 2019 Mar;7(3):e347-e356
pubmed: 30784635
Diagn Progn Res. 2018 Sep 3;2:18
pubmed: 31093566
Am J Public Health. 2013 Jun;103(6):e38-46
pubmed: 23597377
Best Pract Res Clin Obstet Gynaecol. 2009 Jun;23(3):287-96
pubmed: 19303368
Obstet Gynecol Clin North Am. 2015 Jun;42(2):289-98
pubmed: 26002167
BJOG. 2011 Oct;118(11):1402-3; discussion 1403-4
pubmed: 21906238
N Engl J Med. 2017 Dec 14;377(24):2313-2324
pubmed: 29236628
Resuscitation. 2004 Jun;61(3):257-63
pubmed: 15172703
Emerg Med J. 2008 Oct;25(10):674-8
pubmed: 18843068
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Resuscitation. 2004 Aug;62(2):137-41
pubmed: 15294398
BMC Pregnancy Childbirth. 2020 May 27;20(1):324
pubmed: 32460720
BMC Pregnancy Childbirth. 2013 Jul 04;13:141
pubmed: 23826935
BMC Med. 2010 Nov 10;8:71
pubmed: 21067593
BJOG. 2014 Mar;121 Suppl 1:76-88
pubmed: 24641538
Lancet Glob Health. 2014 Jun;2(6):e323-33
pubmed: 25103301
Eval Health Prof. 2013 Mar;36(1):44-66
pubmed: 22615498
Lancet. 2006 Oct 7;368(9543):1284-99
pubmed: 17027735
BMC Pregnancy Childbirth. 2016 Jan 28;16:24
pubmed: 26821716
BMJ. 2003 Nov 1;327(7422):1014
pubmed: 14593033
Med J Aust. 2000 Sep;173(5):236-40
pubmed: 11130346
Eur J Obstet Gynecol Reprod Biol. 2016 Dec;207:11-17
pubmed: 27792988
Br J Anaesth. 2004 Jun;92(6):882-4
pubmed: 15064245
Lancet. 2010 Feb 6;375(9713):490-9
pubmed: 20071021
Anaesthesia. 1999 Sep;54(9):853-60
pubmed: 10460556
AIDS Behav. 2017 Nov;21(11):3129-3140
pubmed: 28421356
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
Int J Gynaecol Obstet. 2013 Oct;123(1):58-63
pubmed: 23830870
Crit Care. 2004 Oct;8(5):373-81
pubmed: 15469601
BMC Pregnancy Childbirth. 2014 Jul 23;14:244
pubmed: 25056517
Resuscitation. 2010 Sep;81(9):1209-11
pubmed: 20598425
Resuscitation. 2004 Sep;62(3):275-82
pubmed: 15325446
Lancet Glob Health. 2018 Nov;6(11):e1196-e1252
pubmed: 30196093
Telemed J E Health. 2016 Jul;22(7):564-71
pubmed: 27172448
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Obstet Gynecol. 2013 Nov;122(5):1122-1131
pubmed: 24150027
J Obstet Gynecol Neonatal Nurs. 2014 Nov-Dec;43(6):771-9
pubmed: 25203897
Anaesthesia. 2013 Apr;68(4):354-67
pubmed: 23488833
J Med Eng Technol. 2010 Jan;34(1):51-63
pubmed: 19929237
JAMA. 2016 Feb 23;315(8):762-74
pubmed: 26903335
Lancet. 2016 Jan 30;387(10017):462-74
pubmed: 26584737

Auteurs

Adeline A Boatin (AA)

Department of Obstetrics and Gynecology, Massachusetts General Hospital, 55 Fruit Street, Founders 5, Boston, MA, USA. adeline_boatin@mgh.harvard.edu.
Center for Global Health, Massachusetts General Hospital, Boston, MA, USA. adeline_boatin@mgh.harvard.edu.
Harvard Medical School, Boston, USA. adeline_boatin@mgh.harvard.edu.
Program for Global Surgery and Social Change, Boston, USA. adeline_boatin@mgh.harvard.edu.

Joseph Ngonzi (J)

Department of Obstetrics and Gynecology, Mbarara University of Science and Technology, Mbarara, Uganda.

Blair J Wylie (BJ)

Harvard Medical School, Boston, USA.
Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Henry M Lugobe (HM)

Department of Obstetrics and Gynecology, Mbarara University of Science and Technology, Mbarara, Uganda.

Lisa M Bebell (LM)

Center for Global Health, Massachusetts General Hospital, Boston, MA, USA.
Harvard Medical School, Boston, USA.
Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

Godfrey Mugyenyi (G)

Department of Obstetrics and Gynecology, Mbarara University of Science and Technology, Mbarara, Uganda.

Sudi Mohamed (S)

Department of Obstetrics and Gynecology, Mbarara University of Science and Technology, Mbarara, Uganda.

Kenia Martinez (K)

Department of Obstetrics and Gynecology, Mbarara University of Science and Technology, Mbarara, Uganda.

Nicholas Musinguzi (N)

Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.

Christina Psaros (C)

Harvard Medical School, Boston, USA.
Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.

Joshua P Metlay (JP)

Harvard Medical School, Boston, USA.
Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

Jessica E Haberer (JE)

Center for Global Health, Massachusetts General Hospital, Boston, MA, USA.
Harvard Medical School, Boston, USA.
Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH